Systems pharmacology modeling of drug‐induced hyperbilirubinemia: Differentiating hepatotoxicity and inhibition of enzymes/transporters

Elevations in serum bilirubin during drug treatment may indicate global liver dysfunction and a high risk of liver failure. However, drugs also can increase serum bilirubin in the absence of hepatic injury by inhibiting specific enzymes/transporters. We constructed a mechanistic model of bilirubin d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, K, Battista, C, Woodhead, JL, Stahl, SH, Mettetal, JT, Watkins, PB, Siler, SQ, Howell, BA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367379/
https://www.ncbi.nlm.nih.gov/pubmed/28074467
http://dx.doi.org/10.1002/cpt.619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367379/
https://www.ncbi.nlm.nih.gov/pubmed/28074467
http://dx.doi.org/10.1002/cpt.619

Ejemplares similares